Stent patency rates and prognostic factors of endovascular intervention for iliofemoral vein occlusion in post-thrombotic syndrome

• Published in: BMC surgery Vol. 22; no. 1; pp. 1 - 269
• Main Authors: Chen, Rencong, Feng, Ruijia, Jiang, Suiting, Chang, Guangqi, Hu, Zuojun, Yao, Chen, Jia, Benyuan, Wang, Shenming, Wang, Siwen
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 12.07.2022; BioMed Central; BMC
• Subjects: Anticoagulants; Balloon treatment; Blood clot; Cardiovascular system; Catheters; Compression therapy; Dilation; Endovascular intervention; Health aspects; Iliofemoral stent; Iliofemoral vein; Implantation; Implants; Medical prognosis; Medical research; Medicine, Experimental; Occlusion; Patency rate; Patients; Post-thrombotic syndrome; Prognosis; Quality of life; Stent (Surgery); Stents; Subgroups; Surgical implants; Thromboembolism; Thrombosis; Tomography; Ulcers; Ultrasonic imaging; Veins & arteries
• ISSN: 1471-2482; 1471-2482
• DOI: 10.1186/s12893-022-01714-9

Abstract Objective Post-thrombotic syndrome (PTS), an important complication of deep venous thrombosis (DVT), adversely affects patients’ quality of life. Endovascular intervention in PTS can relieve symptoms rapidly with high therapeutic value. This study mainly focuses on how to improve postoperative stent patency rates and aims to find prognostic factors impacting patency. Methods According to the specific inclusion and exclusion criteria, PTS patients who underwent endovascular intervention at the First Affiliated Hospital of Sun Yat-sen University from December 1, 2014, to December 31, 2019, were included in this single-center prospective study. Follow-up data were collected and analyzed regularly over 2 years. Results Overall, 31 PTS patients were enrolled in the study. The mean age of these patients was 55.39 ± 11.81, including 19 male patients. Stent implantation was successful in 22 PTS patients, with a technical success rate of 70.97%. The average Villalta scores of the stent-implanted group and the non-stent-implanted group were 5.95 ± 2.57 and 5.78 ± 2.95, respectively, with no significant difference observed. In the stent-implanted group, the perioperative patency rate was 81.81% (18/22), and the follow-up patency rates were 68.18% (15/22) within 3 months, 59.09% (13/22) within 6 months, 45.45% (10/22) within 1 year, and 36.36% (8/22) within 2 years. Based on the stent placement segments, the 22 PTS patients were divided into two subgroups: the iliofemoral vein balloon dilation + iliofemoral vein stent implantation (FV-S) subgroup and the iliofemoral vein balloon dilation + iliac vein stent implantation (FV-B) subgroup. In the FV-S subgroup, the perioperative patency rate was 100.00% (14/14), and the follow-up patency rates were 85.71% (12/14), 71.43% (10/14), 57.14% (8/14) and 50.00% (7/14), which were higher than those for overall stent patency of all patients. The postoperative patency rates in the FV-B subgroup were 50.00% (4/8), 37.50% (3/8), 37.50% (3/8), 25.00% (2/8), and 12.50% (1/8). The secondary postoperative patency rates in the FV-B subgroup were 100.00% (8/8), 87.50% (7/8), 75.00% (6/8), 62.50% (5/8) and 50.00% (4/8). Conclusions For PTS patients with iliofemoral vein occlusion but patent inflow, iliofemoral vein stent implantation is a more efficient therapeutic option than iliofemoral vein balloon dilation with iliac vein stent implantation for PTS patients.